Yu-Qiong Guo

Injectable hyaluronic acid/polyvinyl alcohol/ferrocene-based hydrogel local delivery platform toward synergistic chemotherapy/ferroptosis therapy of breast cancer.

Both in vitro and in vivo results demonstrated that BPOD held remarkable anti-breast-cancer activity with reduced systemic toxicity, providing novel technical approaches and strategies for addressing key challenges in clinical treatment of breast cancer.